99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer

Model NO.: pharmaceutical grade
Category: Anti-Cancer
Trademark: BIOCAR
Transport Package: Silver Foil Bag
Specification: 10g, 100g. 1kg
Origin: China
HS Code: 3001200010
Model NO.: pharmaceutical grade
Category: Anti-Cancer
Trademark: BIOCAR
Transport Package: Silver Foil Bag
Specification: 10g, 100g. 1kg
Origin: China
HS Code: 3001200010

1. AZD-9291 Details:
Name:AZD-9291
Synonyms:N(2{[2(diMethylaMino)ethyl](Methyl)aMino}4Methoxy5{[4(1Methyl1Hindol3yl)pyriMidin2yl]aMino}phenyl)prop2enaMide;
N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD9291;
CAS:1421373-65-0 
MF:C28H33N7O2 
MW:499.61 
Feature:Orally bioavailable mutant-selective EGFR inhibitor that has been tested in Phase III clinical trials for treatment of Non-Small Cell Lung Cancer.
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer


2. AZD-9291 Usage:
Cell lines.
Human lung cancer cells with EGFR-mutations or wild type EGFR stable expression

Preparation method
The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.
 
3. AZD-9291 Application:
AZD9291 administered once daily orally at 5 mg/kg caused profound regression of tumours across EGFRm+ (PC9; 178% growth inhibition) and EGFRm+/T790M (H1975; 119% growth inhibition) tumour models in vivo,after 14 days dosing. Furthermore 5 mg/kg AZD9291 was sufficient to cause significant shrinkage of EGFRm+ and EGFRm+/T790M transgenic mouse lung tumours. Tumour growth inhibition was associated with profound inhibition of EGFR phosphorylation and key downstream signaling pathways such as AKT and ERK. Chronic long-term treatment of PC9 and H1975 xenograft tumours with AZD9291 led to a complete and sustained macroscopic response, with no visible tumours after 40 days dosing, and being maintained beyond 100 days. Furthermore, pre-clinical data also indicates that AZD9291 could target tumours that have acquired resistance to the more recently identified HER2-amplification mechanism, thus potentially extending its benefit in TKI resistant patients.
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer
 

1. AZD-9291 Details:
Name:AZD-9291
Synonyms:N(2{[2(diMethylaMino)ethyl](Methyl)aMino}4Methoxy5{[4(1Methyl1Hindol3yl)pyriMidin2yl]aMino}phenyl)prop2enaMide;
N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD9291;
CAS:1421373-65-0 
MF:C28H33N7O2 
MW:499.61 
Feature:Orally bioavailable mutant-selective EGFR inhibitor that has been tested in Phase III clinical trials for treatment of Non-Small Cell Lung Cancer.
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer


2. AZD-9291 Usage:
Cell lines.
Human lung cancer cells with EGFR-mutations or wild type EGFR stable expression

Preparation method
The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.
 
3. AZD-9291 Application:
AZD9291 administered once daily orally at 5 mg/kg caused profound regression of tumours across EGFRm+ (PC9; 178% growth inhibition) and EGFRm+/T790M (H1975; 119% growth inhibition) tumour models in vivo,after 14 days dosing. Furthermore 5 mg/kg AZD9291 was sufficient to cause significant shrinkage of EGFRm+ and EGFRm+/T790M transgenic mouse lung tumours. Tumour growth inhibition was associated with profound inhibition of EGFR phosphorylation and key downstream signaling pathways such as AKT and ERK. Chronic long-term treatment of PC9 and H1975 xenograft tumours with AZD9291 led to a complete and sustained macroscopic response, with no visible tumours after 40 days dosing, and being maintained beyond 100 days. Furthermore, pre-clinical data also indicates that AZD9291 could target tumours that have acquired resistance to the more recently identified HER2-amplification mechanism, thus potentially extending its benefit in TKI resistant patients.
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer
 

Manual Massage Collapsible Foot Spa Massager

The Manual Massage Foldable Foot Spa Massager is a portable compact device designed to give your feet a relaxing massage experience. Its foldable design makes it easy to store and transport, making it ideal for the frequent traveler.

Massagers typically have multiple massage rollers that apply pressure to different areas of the foot, providing a deep-tissue massage that can help relieve tension and improve circulation. Some models also feature heating and vibration to further enhance the massage experience.

To use the massager, you simply fill it with water and turn it on. The water will heat up and the massage rollers will go into action to provide a soothing massage that will help relax your feet.

Overall, the Manual Massage Foldable Foot Spa Massager is an excellent choice for anyone looking to relieve foot pain and tension in the comfort of their own home.

Manual Massage Collapsible Foot Spa Massager,Foot Bath Massager Machine,Electric Heated Foot Spa,Foot Bath Tub

Huaian Mimir Electric Appliance Co., LTD , https://www.mimirfootbath.com